| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |